Large-scale testing (Phase 3)Study completedNCT04994483What this trial is testingSimufilam 100 mg for Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Cassava Sciences, Inc. 804
Not applicableNot Yet RecruitingNCT06978946What this trial is testingDeep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia PatientsWho this might be right forAlzheimer DiseaseLewy Body Dementia (LBD)Frontotemporal Dementia (FTD)+2 more RenJi Hospital 85
Testing effectiveness (Phase 2)Study completedNCT05004688What this trial is testingA Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate ADWho this might be right forMild Cognitive ImpairmentMild DementiaModerate Dementia+1 more Steven E Arnold, MD 15
Large-scale testing (Phase 3)Study completedNCT01955161What this trial is testingStudy of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With DonepezilWho this might be right forAlzheimer's Disease H. Lundbeck A/S 933
Not applicableLooking for participantsNCT07208162What this trial is testingSHARE Adaptation Intervention for African-American FamiliesWho this might be right forMild DementiaModerate Dementia Benjamin Rose Institute on Aging 120
Testing effectiveness (Phase 2)Looking for participantsNCT06995573What this trial is testingAssess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease NSC-Therapeutics 90
Testing effectiveness (Phase 2)Ended earlyNCT06721156What this trial is testingEvaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)Who this might be right forAlzheimer DiseaseDementia Merck Sharp & Dohme LLC 369
Early research (Phase 1)Study completedNCT00766363What this trial is testingSafety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseCentral Nervous System Diseases FORUM Pharmaceuticals Inc 49
Testing effectiveness (Phase 2)UnknownNCT02672306What this trial is testingSafety and Exploratory Efficacy Study of UCMSCs in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease South China Research Center for Stem Cell and Regenerative Medicine 16
Large-scale testing (Phase 3)UnknownNCT00217763What this trial is testingEuropean Study of 3APS in Mild to Moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer's Disease Bellus Health Inc. - a GSK company 930
Early research (Phase 1)Study completedNCT01125631What this trial is testingMultiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 8
Not applicableUnknownNCT02227953What this trial is testingA Pilot Study of tDCS for Mild to Moderate Alzhemier's DiseaseWho this might be right forAlzheimer's Disease Samsung Medical Center 20
Not applicableStudy completedNCT05637801What this trial is testingA Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)Who this might be right forAlzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more Cognito Therapeutics, Inc. 673
Large-scale testing (Phase 3)Study completedNCT00506415What this trial is testingComparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive DeclineWho this might be right forAlzheimer Disease Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)UnknownNCT03865017What this trial is testingA Safety and Tolerability Study of GB301Who this might be right forAlzheimer Disease VTBIO Co. LTD 20
Large-scale testing (Phase 3)Study completedNCT00829374What this trial is testingSafety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on DonepezilWho this might be right forAlzheimer's Disease Medivation, Inc. 1,003
Testing effectiveness (Phase 2)Ended earlyNCT01238991What this trial is testingLong Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 53
Early research (Phase 1)Study completedNCT01485302What this trial is testingSingle and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's PatientsWho this might be right forAlzheimer's Disease Sanofi 48
Testing effectiveness (Phase 2)Study completedNCT03867253What this trial is testingTesting the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's DiseaseWho this might be right forMild to Moderate Alzheimer's Disease Oryzon Genomics S.A. 24
Testing effectiveness (Phase 2)Study completedNCT01018875What this trial is testingEfficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 242